iShares Nasdaq Biotechnology ETF (IBB)

110.38
Delayed Data
As of Nov 12
 +0.34 / +0.31%
Today’s Change
89.01
Today|||52-Week Range
116.25
+14.47%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

No recent news for iShares Nasdaq Biotechnology ETF.

Performance

1 month+9.64% 3 years+4.88%
3 months+4.40% 5 years+2.37%
1 year+2.25% Since inception+6.73%
Data through 11/12/2019

Quote Details

Previous close$110.04
Open day’s range109.82 – 111.33
Net asset value (NAV)109.98 (11/11/2019)
Daily volume2,516,855
Average volume (3 months)2,352,113
Data as of 4:00pm ET, 11/12/2019

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+2.37%+7.05%
Expense Gross exp ratio0.47%1.24%
Risk 5 year sharpe ratio0.150.44
Net assets$6.9B$3.1B
Average market cap$14.8B$34.6B
Average P/E18.323.8
Dividend / Share--0.26%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IXJ iShares Global Healthcare ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene8.56%
AMGN Amgen7.84%
GILD Gilead Sciences7.69%
VRTX Vertex Pharmaceuticals Inc6.70%
ILMN Illumina Inc5.79%
BIIB Biogen5.22%
REGN Regeneron Pharmaceuticals4.05%
ALXN Alexion Pharmaceuticals Inc3.27%
SGEN Seattle Genetics Inc2.53%
INCY Incyte Corp2.50%